Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment
British Journal of Pharmacology · 2026-12 · 183 (23) · 6903-6926
DOI: 10.1111/bph.70633 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 24.08.2026. Verfasst von Lina Hao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Wnt Signaling Pathway, Tretinoin. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background and Purpose Diabetic cardiomyopathy (DCM) lacks effective therapies because of complex mechanisms. This study aims to develop a single‐atom nanozyme for integrated antioxidant and signalling regulation in DCM. Experimental Approach A graphene quantum dot‐templated single‐atom Pt‐N‐C nanozyme (PtsaN‐C) was synthesised for all‐trans retinoic acid (ATRA) delivery (PtsaN‐C@ATRA). In vitro antioxidant activity and in vivo efficacy were evaluated in DCM mice, combined with scRNA‐seq for mechanistic analysis. Key Results PtsaN‐C@ATRA improved cardiac function, reduced fibrosis/apoptosis and activated the Rara/Wnt/β‐catenin axis to promote cardiomyocyte differentiation. Conclusions and Implications PtsaN‐C@ATRA represents a novel strategy merging nanozyme catalysis with transcriptional regulation, offering potential for clinical translation in DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zitieren
APA
Hao, L., & Qu, X. (2026). Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment. British Journal of Pharmacology, 183(23), 6903-6926. https://doi.org/10.1111/bph.70633
Vancouver
Hao L, Qu X. Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment. British Journal of Pharmacology. 2026;183(23):6903-6926. doi:10.1111/bph.70633
BibTeX
@article{Hao2026,
author = {Hao, Lina and Qu, Xiufen},
title = {Single‐atom Pt‐N‐C nanozyme targets Rara/Wnt/β‐catenin axis for diabetic cardiomyopathy treatment},
journal = {British Journal of Pharmacology},
year = {2026},
volume = {183},
number = {23},
pages = {6903--6926},
doi = {10.1111/bph.70633}
}
EUVIMED